Search

Search bills, members, committees and pages...

H.R. 6610

U.S. HouseIn House Committee

Summary

H.R. 6610, the Pharmacists Fight Back [in Federal Employee Health Benefit Plans Act], was introduced in the House on Dec 11, 2025 by Rep. Jake Auchincloss (D) with 42 co-sponsors. It last saw action on Jul 22, 2026: Ordered to be Reported (Amended) by the Yeas and Nays: 40 - 2.


Record

Text

H.R. 6610 has 42 co-sponsors.

hb6610/introduced-in-house.txt
119 HR 6610 IH: Pharmacists Fight Back [in Federal Employee Health Benefit Plans Act]
U.S. House of Representatives
2025-12-11
text/xml
EN
Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
I 119th CONGRESS 1st Session H. R. 6610 IN THE HOUSE OF REPRESENTATIVES December 11, 2025 Mr. Auchincloss (for himself, Mr. Comer , Mrs. Harshbarger , Mr. Carter of Georgia , Mr. Ciscomani , Mr. Moulton , Mr. Deluzio , Ms. Tlaib , Ms. Budzinski , Mr. Krishnamoorthi , Mr. Khanna , Mr. Cohen , Ms. Pressley , Mr. Vicente Gonzalez of Texas , Mr. Moore of Alabama , Mr. Subramanyam , Mr. Pocan , Mr. Bishop , and Ms. McCollum ) introduced the following bill; which was referred to the Committee on Oversight and Government Reform A BILL
To amend chapter 89 of title 5, United States Code, to limit the costs of pharmacy benefit managers with respect to Federal employee health benefit plans, and for other purposes.
1.
Short title
This Act may be cited as the Pharmacists Fight Back [in Federal Employee Health Benefit Plans Act] .
2.
Pharmacy payment and reimbursement requirements
(a)
In general
Section 8904 of title 5, United States Code, is amended by adding at the end the following new subsection:
(c)
(1)
The Office of Personnel Management may not contract for or approve a health benefits plan under section 8903 of this title unless such plan—
(A)
requires any pharmacy benefits manager administering prescription drug benefits on behalf of such health benefits plan, either directly or through an affiliate of such pharmacy benefits manager, to—
(i)
reimburse an in-network pharmacy for the ingredient cost of a prescription drug in an amount equal to the sum of—
(I)
the national average drug acquisition cost for the drug on the day of claim adjudication (or, in the case of a drug that does not appear on the national average drug acquisition cost index, the wholesale acquisition cost for such prescription drug); and
(II)
the lesser of the amount that is equal to 4 percent of the amount described in subclause (I) or $50;
(ii)
pay an in-network pharmacy a professional dispensing fee that is equal to the professional dispensing fee paid by the State in which the pharmacy is located under title XIX of the Social Security Act ( 42 U.S.C. 1396 et seq. ) for dispensing a prescription drug; and
(iii)
for any manufacturer rebate such pharmacy benefits manager or affiliate thereof receives in connection with a drug obtained at an in-network pharmacy by an individual pursuant to such prescription drug benefits, such pharmacy benefits manager or affiliate shall—
(I)
apply, at the point of sale of such drug, a reduction to the amount of any coinsurance or copayment owed by such individual with respect to such drug, such that the amount of coinsurance or copayment so owed is calculated based on the net cost of the drug, including such rebate; and
(II)
remit to the carrier for such health benefits plan an amount equal to the amount of such rebate, less the amount by which the coinsurance or copayment owed by such individual with respect to such drug was reduced under subclause (I);
(B)
prohibits such pharmacy benefits manager and any affiliate thereof from—
(i)
directing, ordering, or requiring an individual enrolled in such health benefits plan to use a specific pharmacy, including a pharmacy that is an affiliate of such pharmacy benefits manager, for the purpose of filling a prescription for a prescription drug or receiving services;
(ii)
advertising, marketing, or promoting a specific pharmacy, including a pharmacy that is an affiliate of such pharmacy benefits manager, over another in-network pharmacy;
(iii)
creating any network or engaging in any practice, including accreditation or credentialing standards, day supply limitations, or delivery method limitations, that excludes an in-network pharmacy or restricts an in-network pharmacy from filling a prescription for a prescription drug for which benefits are available under such health benefits plan;
(iv)
directly or indirectly engaging in any practice that attempts to influence or induce a pharmaceutical manufacturer to limit the distribution of a prescription drug to a small number of pharmacies or certain types of pharmacies, or to restrict distribution of such drug to non-affiliate pharmacies; or
(v)
requiring an individual enrolled in such health benefits plan to reimburse the pharmacy benefits manager or affiliate for the dispensing fee paid to an in-network pharmacy pursuant to subparagraph (A)(ii) with respect to a prescription drug obtained at such pharmacy by such individual, or otherwise increasing the amount owed by such individual with respect to such drug to account for such dispensing fee;
(C)
prohibits any such pharmacy benefits manager from lowering, imposing a fee on, or otherwise make any adjustment to a prescription drug claim at the time the claim for such drug is adjudicated or after the claim is adjudicated that reduces the amount a pharmacy is reimbursed for such drug pursuant to subparagraph (A), including by charging any fee to such pharmacy that is not associated with a prescription drug claim; and
(D)
requires the carrier providing such health benefits plan to cooperate with any inspection of such carrier carried out under section 8902b(a)(3)(B) of this title, including by making available to the Office such documents, personnel, and facilities of the carrier as and when determined necessary to Office to carry out such inspection.
(2)
In this subsection:
(A)
The term affiliate means an entity, including a pharmacy, that directly or indirectly through one or more intermediaries—
(i)
owns, in whole or in part, or controls a pharmacy benefits manager;
(ii)
is owned, in whole or in part, or controlled by that is a pharmacy benefits manager; or
(iii)
is a subsidiary of or owned, in whole or in part, or controlled by an entity that owns or controls a pharmacy benefits manager.
(B)
The term beneficiary means a person who receives prescription drug benefits under a health benefits plan.
(C)
The term in-network pharmacy means a pharmacy that is licensed by the State board of pharmacy in the State in which such pharmacy is located, that fills or seeks to fill a prescription for a prescription drug for a beneficiary, and is not barred from participating in the program under this chapter under section 8902a.
(D)
The term pharmacy benefits manager means a person, business entity, affiliate, or other entity that performs pharmacy benefits management services.
(E)
The term pharmacy benefits management services —
(i)
means the managing or administration of a plan or program that pays for, reimburses, and covers the cost of prescription drugs and medical devices; and
(ii)
includes the processing and payment of claims for prescription drugs and the adjudication of appeals or grievances related to the prescription drug benefit.
(F)
The term prescription drug means a prescription drug covered by a health benefits plan that is dispensed to a beneficiary for self-administration.
.
(b)
Noncompliance penalties
(1)
In general
Chapter 89 of title 5, United States Code, is amended by inserting after section 8902a the following new section:
8902b.
Pharmacy benefit manager-related sanctions
(a)
Monetary penalties
(1)
In general
Except as otherwise provided by this subsection and subsection (c), if the Office of Personnel Management determines that a pharmacy benefits manager violated a requirement or prohibition applicable to such pharmacy benefits manager with respect to a health benefits plan pursuant to section 8904(c)(1) of this title, the Office shall, in addition to any other penalties that may be prescribed by law and after consultation with the Attorney General, impose a civil monetary penalty of $10,000 for each such violation—
(A)
on such pharmacy benefits manager; and
(B)
if, during the 10-year period ending on the imposition of such civil monetary penalty, not fewer than five civil monetary penalties have been imposed on such pharmacy benefits manager under this paragraph with respect to health benefit plans provided by the carrier providing such health benefits plan, on such carrier.
(2)
Maximum penalty amount
(A)
Pharmacy benefit managers
For each carrier providing a health benefits plan with respect to which a pharmacy benefits manager is determined to have committed a violation described in paragraph (1), the total amount of civil monetary penalties imposed on such pharmacy benefits manager under such paragraph for violations with respect to the health benefit plans of such carrier many not exceed $100,000 during any 10-year period.
(B)
Carriers
The total amount of civil monetary penalties imposed on a carrier under paragraph (1) may not exceed $50,000 during any 10-year period.
(3)
Remediation plan
(A)
In general
Not later than 60 days after the date on which the Office of Personnel Management imposes a civil monetary penalty on a carrier under paragraph (1) with respect to a pharmacy benefits manager that is the fifth such civil monetary penalty imposed on such carrier with respect to such pharmacy benefits manager in a 10-year period, such carrier shall develop and submit to the Office of Personnel Management a plan to ensure that each pharmacy benefit manager administering prescription drug benefits on behalf of a health benefits plan provided by such carrier complies with the requirements and prohibitions applicable to such pharmacy benefit manager pursuant to section 8904(c)(1).
(B)
Oversight
Not later than 60 days after the date on which a carrier submits plan under subparagraph (A), and with such frequency thereafter as determined appropriate by the Office of Personnel Management, the Office of Personnel Management shall inspect such carrier to assess the compliance of such carrier with such plan.
(4)
Sequential imposition
For the purposes of this subsection, any civil monetary penalties concurrently imposed under paragraph (1) shall be deemed to be imposed sequentially.
(5)
Civil action
(A)
In general
A civil action to recover a civil monetary penalty imposed under this subsection shall be brought by the Attorney General in the name of the United States, and may be brought in the United States district court for the district where the claim involved was presented or where the pharmacy benefits manager or carrier subject to such civil monetary penalty resides.
(B)
Treatment of amounts recovered
Amounts recovered under this subsection shall be paid to the Office of Personnel Management for deposit into the Employees Health Benefits Fund.
(6)
Deduction from amounts owed
The amount of a civil monetary penalty imposed under this subsection may be deducted from any sum then or later owing by the United States to the party against whom the penalty or assessment has been levied.
(7)
Statute of limitations
The Office of Personnel Management may not initiate any action to impose a civil monetary penalty on a pharmacy benefits manager or carrier under this subsection later than 6 years after the date of the violation of the requirement or prohibition by the pharmacy benefits manager for which such civil monetary penalty would be imposed.
(b)
Debarment
(1)
In general
The Office of Personnel Management shall bar a pharmacy benefits manager from administering prescription drug benefits on behalf of a health benefits plan, either directly of through an affiliate of such pharmacy benefits manager, under the program under this chapter if, in any 10-year period, the Office of Personnel Management imposes 10 or more civil monetary penalties on such pharmacy benefits manager under subsection (a).
(2)
Effective date
Except as provided by subsection (c), debarment of a pharmacy benefits manager under paragraph (1) shall be effective on the date that is 90 days after the date on which the Office of Personnel Management imposes the first civil monetary penalty pursuant to which such pharmacy benefits manager is subject to such debarment.
(3)
Payment prohibited
(A)
In general
Notwithstanding section 8902(j) or any other provision of this chapter, if, under this section a pharmacy benefits manager is debarred under paragraph (1), no payment may be made by a carrier pursuant to any contract under this chapter (either to such pharmacy benefits manager or by reimbursement) for any service or supply furnished by such pharmacy benefits manager during the period of the debarment.
(B)
Subcontract contracts
Each contract under this chapter shall contain such provisions as may be necessary to carry out subparagraph (A) and the other provisions of this section.
(4)
Termination
The debarment of a pharmacy benefits manager under paragraph (1) shall be immediately terminated if all civil monetary penalties pursuant to which such pharmacy benefits manager is subject to such debarment are overturned or wholly set aside on appeal.
(5)
Rule of construction
For the purposes of this subsection, a civil monetary penalty is a civil monetary penalty pursuant to which a pharmacy benefits manager is subject to debarment under paragraph (1) if such civil monetary penalty is not less than the tenth civil monetary penalty imposed on such pharmacy benefits manager under subsection (a) during a 10-year period that—
(A)
has not been appealed and for which the period of appeal has elapsed; or
(B)
has been appealed, all appeals have been exhausted, and has not be overturned or wholly set aside.
(c)
Hearing
(1)
In general
The Office of Personnel Management shall not make a determination adverse to a pharmacy benefits manager or carrier under subsection (a) or a determination adverse to a pharmacy benefits manager (b) until such pharmacy benefits manager or carrier, as applicable, has been given reasonable notice and an opportunity for the determination to be made after a hearing as provided in accordance with this subsection.
(2)
Hearing required
Any pharmacy benefits manager or carrier that is the subject of an adverse determination by the Office of Personnel Management under this section shall be entitled to reasonable notice and an opportunity to request a hearing on the record, and to judicial review as provided in this subsection after the Office of Personnel Management makes a final decision regarding such adverse determination.
(3)
Hearing criteria
The Office of Personnel Management shall grant a request for a hearing under paragraph (2) upon a showing that due process rights have not previously been afforded with respect to any finding of fact which is relied upon as a cause for an adverse determination under this section. Such hearing shall be conducted without regard to subchapter II of chapter 5 and chapter 7 of this title by a hearing officer who shall be designated by the Director of the Office of Personnel Management and who shall not otherwise have been involved in the adverse determination being appealed.
(4)
Request for hearing
A request for a hearing under paragraph (2) shall be filed within such period and in accordance with such procedures as the Office of Personnel Management shall prescribe by regulation.
(5)
Appeal
(A)
In general
Any pharmacy benefits manager or carrier adversely affected by a final decision of the Office of Personnel Management regarding an adverse determination that is made after a hearing under paragraph (2) with respect to such adverse determination and to which such pharmacy benefits manager or carrier was a party may seek review of such final decision in the United States District Court for the District of Columbia or for the district in which the pharmacy benefits manager or carrier resides or has his or her principal place of business by filing a notice of appeal in such court within 60 days after the date the decision is issued, and by simultaneously sending copies of such notice by certified mail to the Director of the Office and to the Attorney General.
(B)
Answer
In answer to an appeal filed under subparagraph (A), the Director of the Office of Personnel Management shall promptly file in the relevant court a certified copy of the transcript of the record of the hearing conducted under paragraph (2) and other evidence upon which the findings and final decision complained of are based.
(C)
Court authority
With respect to an appeal filed under subparagraph (A), the court shall have power to enter, upon the pleadings and evidence of record, a judgment affirming, modifying, or setting aside, in whole or in part, the final decision of the Office of Personnel Management that is the subject of such appeal, with or without remanding the case for a rehearing. The court shall not set aside or remand such final decision unless there is not substantial evidence on the record, taken as whole, to support the such final decision or unless the actions of the Office of Personnel Management with respect to such final decision constitutes an abuse of discretion.
(6)
Defense forfeiture
Matters that were raised or that could have been raised in a hearing under paragraph (2) or an appeal under paragraph (5) may not be raised as a defense to a civil action by the United States to collect a civil monetary penalty imposed under subsection (a).
(d)
Affiliate; pharmacy benefits manager; prescription drug defined
In this section, the terms affiliate , pharmacy benefits manager and prescription drug have the meanings given such terms, respectively, in section 8904(c) of this title.
.
(2)
Clerical amendment
The table of sections for chapter 89 of title 5, United States Code, is amended by inserting after the item relating to section 8902a the following new item:
8902b. Pharmacy benefit manager-related sanctions.
.
(c)
Conforming amendment
Section 8903a(b) of title 5, United States Code, is amended—
(1)
in paragraph (3), by striking and at the end;
(2)
in paragraph (4), by striking the period at the end and inserting ; and ; and
(3)
by adding at the end the following new paragraph:
(5)
complies with the requirements under section 8904(c).
.
(d)
Effective date
The amendments made by this Act shall take effect on the date that is one year after the date of the enactment of this Act.

Tracker

The tracker indicates the progress of this legislation as it moves through the legislative process.

  1. Introduced2025-12-11
  2. Passed House
  3. Passed Senate
  4. Conference
  5. To President
  6. Became Law

To amend chapter 89 of title 5, United States Code, to limit the costs of pharmacy benefit managers with respect to Federal employee health benefit plans, and for other purposes.

Sponsors

Rep. Jake Auchincloss (D) sponsors H.R. 6610, and 42 members have co-sponsored it, 18 of them from the day it was introduced.

Committees

H.R. 6610 went before 1 committee: Oversight and Government Reform.

Oversight and Government Reform
Oversight and Government Reform
Markup By · Jul 22, 2026 · 696 Bills

Actions

H.R. 6610 has taken 4 actions since Dec 11, 2025, the latest on Jul 22, 2026.

ChamberAction
Jul 22, 2026
House
Committee Consideration and Mark-up Session HeldOversight and Government Reform Committee
Jul 22, 2026
House
Ordered to be Reported (Amended) by the Yeas and Nays: 40 - 2.Oversight and Government Reform Committee
Dec 11, 2025
House
Introduced in House
Dec 11, 2025
House
Referred to the House Committee on Oversight and Government Reform.Oversight and Government Reform Committee

Votes

H.R. 6610 has not gone to a roll call.

Titles

H.R. 6610 goes by 3 titles, 1 of them short titles.

  • Pharmacists Fight Back [in Federal Employee Health Benefit Plans Act] — Display Title
  • Pharmacists Fight Back [in Federal Employee Health Benefit Plans Act] — Short Title(s) as Introduced
  • To amend chapter 89 of title 5, United States Code, to limit the costs of pharmacy benefit managers with respect to Federal employee health benefit plans, and for other purposes. — Official Title as Introduced

Lobbying

15 clients hired 14 firms and 85 registered lobbyists who named H.R. 6610 in 29 quarterly filings, 2025 to 2026. Reported under the Lobbying Disclosure Act; a filing’s income covers everything its registrant worked that quarter, so the amounts below are the filings’, not this bill’s.

Filed under Medicare/Medicaid, Health Issues, Pharmacy, Budget/Appropriations, Labor Issues/Antitrust/Workplace, Taxation/Internal Revenue Code, Trade (domestic/foreign), Advertising.

Clients

Who paid to be heard, by how many filings named the bill.

ClientBusinessStateFirmsFilingsReported
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATIONno changeDistrict of Columbia14
URAC, INC.Non-profit accreditation entity for healthcare organizations.District of Columbia13$210K
CVS HEALTH (AND SUBSIDIARIES)Health CareDistrict of Columbia13
INDEPENDENT PHARMACY COOPERATIVENational GPO and drug distribution services for independent pharmacies.Wisconsin13
NATIONAL COMMUNITY PHARMACISTS ASSOCIATIONVirginia13
NATIONAL TREASURY EMPLOYEES UNIONDistrict of Columbia13
TRANSPARENCY RISING CORP.Coalition of licensed transparent pharmacy benefit managersVirginia12
TRANSPARENCY-RX CORP.Coalition of licensed transparent pharmacy benefit managersVirginia11$20K
AMERICAN AUTOMOBILE ASSOCIATIONtransportation funding; traffic safety; consumer vehicle issuesDistrict of Columbia11
BLUE CROSS AND BLUE SHIELD ASSOCIATIONDistrict of Columbia11
BLUE CROSS AND BLUE SHIELD OF FLORIDA INCFlorida11
GSK (FKA GLAXOSMITHKLINE INC.)District of Columbia11
GUIDEWELL MUTUAL HOLDING CORPORATIONFlorida11
NATIONAL ASSOCIATION OF LETTER CARRIERSDistrict of Columbia11
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICADistrict of Columbia11

Firms

Registrants who filed on the bill, by filings.

Lobbyists

Named on the filings that cite the bill. The 20 named most often, of 85.

Filings

The documents themselves, on the Senate’s Lobbying Disclosure site, largest reported first.

ClientRegistrantPeriodReportedDocument
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICAPHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA2026 second_quarter$7.4M2nd Quarter - Report
CVS HEALTH (AND SUBSIDIARIES)CVS HEALTH (AND SUBSIDIARIES)2026 second_quarter$3.6M2nd Quarter - Report
CVS HEALTH (AND SUBSIDIARIES)CVS HEALTH (AND SUBSIDIARIES)2026 first_quarter$3.3M1st Quarter - Report
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATIONPHARMACEUTICAL CARE MANAGEMENT ASSOCIATION2026 second_quarter$3.3M2nd Quarter - Report
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATIONPHARMACEUTICAL CARE MANAGEMENT ASSOCIATION2025 fourth_quarter$3.2M4th Quarter - Report
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATIONPHARMACEUTICAL CARE MANAGEMENT ASSOCIATION2026 first_quarter$3M1st Quarter - Amendme…
CVS HEALTH (AND SUBSIDIARIES)CVS HEALTH (AND SUBSIDIARIES)2025 fourth_quarter$2.3M4th Quarter - Report
BLUE CROSS AND BLUE SHIELD ASSOCIATIONBLUE CROSS AND BLUE SHIELD ASSOCIATION2025 fourth_quarter$1.4M4th Quarter - Report
GSK (FKA GLAXOSMITHKLINE INC.)GSK (FKA GLAXOSMITHKLINE INC.)2026 second_quarter$890K2nd Quarter - Report
NATIONAL TREASURY EMPLOYEES UNIONNATIONAL TREASURY EMPLOYEES UNION2025 fourth_quarter$350K4th Quarter - Report
NATIONAL TREASURY EMPLOYEES UNIONNATIONAL TREASURY EMPLOYEES UNION2026 second_quarter$340K2nd Quarter - Report
NATIONAL COMMUNITY PHARMACISTS ASSOCIATIONNATIONAL COMMUNITY PHARMACISTS ASSOCIATION2026 first_quarter$320K1st Quarter - Report
NATIONAL TREASURY EMPLOYEES UNIONNATIONAL TREASURY EMPLOYEES UNION2026 first_quarter$310K1st Quarter - Report
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATIONPHARMACEUTICAL CARE MANAGEMENT ASSOCIATION2026 first_quarter$299.7K1st Quarter - Report
NATIONAL COMMUNITY PHARMACISTS ASSOCIATIONNATIONAL COMMUNITY PHARMACISTS ASSOCIATION2026 second_quarter$270K2nd Quarter - Report
NATIONAL COMMUNITY PHARMACISTS ASSOCIATIONNATIONAL COMMUNITY PHARMACISTS ASSOCIATION2025 fourth_quarter$230K4th Quarter - Report
NATIONAL ASSOCIATION OF LETTER CARRIERSNATIONAL ASSOCIATION OF LETTER CARRIERS2026 second_quarter$140K2nd Quarter - Report
BLUE CROSS AND BLUE SHIELD OF FLORIDA INCBLUE CROSS AND BLUE SHIELD OF FLORIDA, INC.2025 fourth_quarter$90K4th Quarter - Report
URAC, INC.ARNOLD & PORTER KAYE SCHOLER LLP2026 second_quarter$70K2nd Quarter - Report
URAC, INC.ARNOLD & PORTER KAYE SCHOLER LLP2026 first_quarter$70K1st Quarter - Report

Classification

The Congressional Research Service files H.R. 6610 under Health, one of its 31 policy areas, and gives it 6 legislative subjects.

CRS Subjects

CRS assigns every bill one policy area from its 31; H.R. 6610’s is Health.

hr6610/policy-areas.txt
HealthAgriculture and FoodAnimalsArmed Forces and National SecurityArts, Culture, ReligionCivil Rights and Liberties, Minority IssuesCommerceCongressCrime and Law EnforcementEconomics and Public FinanceEducationEmergency ManagementEnergyEnvironmental ProtectionFamiliesFinance and Financial SectorForeign Trade and International FinanceGovernment Operations and PoliticsHousing and Community DevelopmentImmigrationInternational AffairsLabor and EmploymentLawNative AmericansPublic Lands and Natural ResourcesScience, Technology, CommunicationsSocial WelfareSports and RecreationTaxationTransportation and Public WorksWater Resources Development

Legislative Subjects

H.R. 6610 carries 6 of CRS’s legislative subjects, from Civil actions and liability to User charges and fees.

hr6610/subjects.txt
Civil actions and liabilityGovernment employee pay, benefits, personnel managementHealth care costs and insuranceJudicial review and appealsPrescription drugsUser charges and fees

Constitutional authority

The clause the sponsor cites as Congress’s power to enact H.R. 6610, as entered in the Congressional Record.

[Congressional Record Volume 171, Number 209 (Thursday, December 11, 2025)][House]From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]By Mr. AUCHINCLOSS:H.R. 6610.Congress has the power to enact this legislation pursuantto the following:Article I, Section 8 of the United States Constitution[Page H5810]

Source: congress.gov · legiscan.com